The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
An overview of prevalence, determinants and health outcomes of polypharmacy
Open accessAbstract
A high rate of polypharmacy is, in part, a consequence of the increasing proportion of multimorbidity in the ageing population worldwide. Our understanding of the potential harm of taking multiple medications in an older, multi-morbid population, who are likely to be on a polypharmacy regime, is limited. This is a narrative literature review that aims to appraise and summarise recent studies published about polypharmacy. We searched MEDLINE using the search terms polypharmacy (and its variations, e.g. multiple prescriptions, inappropriate drug use, etc.) in titles. Systematic reviews and original studies in English published between 2003 and 2018 were included. In this review, we provide current definitions of polypharmacy. We identify the determinants and prevalence of polypharmacy reported in different studies. Finally, we summarise some of the findings regarding the association between polypharmacy and health outcomes in older adults, with a focus on frailty, hospitalisation and mortality. Polypharmacy was most often defined in terms of the number of medications that are being taken by an individual at any given time. Our review showed that the prevalence of polypharmacy varied between 10% to as high as around 90% in different populations. Chronic conditions, demographics, socioeconomics and self-assessed health factors were independent predictors of polypharmacy. Polypharmacy was reported to be associated with various adverse outcomes after adjusting for health conditions. Optimising care for polypharmacy with valid, reliable measures, relevant to all patients, will improve the health outcomes of older adult population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62167-9 · Cited by 9,503
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972
What is polypharmacy? A systematic review of definitions
Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017) · BMC Geriatrics · doi:10.1186/s12877-017-0621-2 · Cited by 3,293
Aging with multimorbidity: A systematic review of the literature
Marengoni, A., Angleman, S., Melis, R., Mangialasche, F., Karp, A., Garmen, A., Meinow, B., & Fratiglioni, L. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2011.03.003 · Cited by 3,092
Clinical consequences of polypharmacy in elderly
Maher, R. L., Hanlon, J., & Hajjar, E. R. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2013.827660 · Cited by 1,938
Gnjidic, D., Hilmer, S. N., Blyth, F. M., Naganathan, V., Waite, L., Seibel, M. J., McLachlan, A. J., Cumming, R. G., Handelsman, D. J., & Le Couteur, D. G. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2012.02.018 · Cited by 1,176
The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
Guthrie, B., Makubate, B., Hernandez-Santiago, V., & Dreischulte, T. (2015) · BMC Medicine · doi:10.1186/s12916-015-0322-7 · Cited by 838
Interventions to improve the appropriate use of polypharmacy for older people
Patterson, S. M., Cadogan, C. A., Kerse, N., Cardwell, C. R., Bradley, M. C., Ryan, C., & Hughes, C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008165.pub3 · Cited by 754
Health Outcomes Associated with Polypharmacy in Community‐Dwelling Older Adults: A Systematic Review
Fried, T. R., O'Leary, J., Towle, V., Goldstein, M. K., Trentalange, M., & Martin, D. K. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13153 · Cited by 721
An update on the clinical consequences of polypharmacy in older adults: a narrative review
Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2018.1546841 · Cited by 617
Viktil, K. K., Blix, H. S., Moger, T. A., & Reikvam, A. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02744.x · Cited by 537
The relationship between frailty and polypharmacy in older people: A systematic review
Gutiérrez‐Valencia, M., Izquierdo, M., Cesari, M., Casas‐Herrero, Á., Inzitari, M., & Martínez‐Velilla, N. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13590 · Cited by 480
Cahir, C., Fahey, T., Teeling, M., Teljeur, C., Feely, J., & Bennett, K. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03628.x · Cited by 418
Midão, L., Giardini, A., Menditto, E., Kardas, P., & Costa, E. (2018) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2018.06.018 · Cited by 397
The epidemiology of polypharmacy in older adults: register-based prospective cohort study
Morin, L., Johnell, K., Laroche, M.-L., Fastbom, J., & Wastesson, J. W. (2018) · Clinical Epidemiology · doi:10.2147/clep.s153458 · Cited by 376
Gu, Q., Dillon, C. F., & Burt, V. L. (2010) · PsycEXTRA Dataset · doi:10.1037/e665492010-001 · Cited by 374
Association between polypharmacy and death: A systematic review and meta-analysis
Leelakanok, N., Holcombe, A. L., Lund, B. C., Gu, X., & Schweizer, M. L. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.06.002 · Cited by 355
On behalf of SIMI Investigators, Nobili, A., Licata, G., Salerno, F., Pasina, L., Tettamanti, M., Franchi, C., De Vittorio, L., Marengoni, A., Corrao, S., et al. (2011) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-010-0977-0 · Cited by 312
Lu, W.-H., Wen, Y.-W., Chen, L.-K., & Hsiao, F.-Y. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.141219 · Cited by 240
Prevalence and predictors of polypharmacy among older primary care patients in Germany
Junius-Walker, U., Theile, G., & Hummers-Pradier, E. (2006) · Family Practice · doi:10.1093/fampra/cml067 · Cited by 237
Jyrkkä, J., Enlund, H., Korhonen, M. J., Sulkava, R., & Hartikainen, S. (2009) · Drugs & Aging · doi:10.2165/00002512-200926060-00006 · Cited by 218
Herr, M., Robine, J.-M., Pinot, J., Arvieu, J.-J., & Ankri, J. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3772 · Cited by 215
The epidemiology of polypharmacy
Payne, R. A. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-5-465 · Cited by 209
Payne, R. A., Abel, G. A., Avery, A. J., Mercer, S. W., & Roland, M. O. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12292 · Cited by 204
Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study
Saum, K., Schöttker, B., Meid, A. D., Holleczek, B., Haefeli, W. E., Hauer, K., & Brenner, H. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14718 · Cited by 203
Veronese, N., Stubbs, B., Noale, M., Solmi, M., Pilotto, A., Vaona, A., Demurtas, J., Mueller, C., Huntley, J., Crepaldi, G., et al. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.02.009 · Cited by 194
Prevalence and Predictors of Polypharmacy among Korean Elderly
Kim, H.-A., Shin, J.-Y., Kim, M.-H., & Park, B.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098043 · Cited by 185
Adverse Drug Events as a Cause of Hospitalization in Older Adults
Salvi, F., Marchetti, A., D’Angelo, F., Boemi, M., Lattanzio, F., & Cherubini, A. (2012) · Drug Safety · doi:10.1007/bf03319101 · Cited by 176
Polypharmacy management by 2030: a patient safety challenge.
Mair, A. R., Fernández-Llimós, F., Alonso, A., Harrison, C., Hurding, S., Kempen, T. G. H., Kinnear, M., Michael, N., McIntosh, J., & Wilson, M. (2017) · Edinburgh Napier Research Repository (Edinburgh Napier University) · Cited by 148
Gómez, C., Quiroga, S. V., Bermejo‐Pareja, F., Medrano, M. J., Louis, E. D., & Benito‐León, J. (2014) · Gerontology · doi:10.1159/000365328 · Cited by 147
Bonaga, B., Sánchez‐Jurado, P. M., Martínez-Reig, M., Ariza‐Zafra, G., Rodríguez‐Mañas, L., Gnjidic, D., Salvador, T., & Abizanda, P. (2017) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.07.008 · Cited by 136
Etherton‐Beer, C., Hyde, Z., Almeida, O. P., Norman, P. E., Hankey, G. J., Yeap, B. B., & Flicker, L. A. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03875.x · Cited by 122
Myint, P. K., Fox, C., Kwok, C. S., Luben, R., Wareham, N. J., & Khaw, K. (2014) · Age and Ageing · doi:10.1093/ageing/afu185 · Cited by 120
Self-citationJohnell, K., & Fastbom, J. (2008) · Scandinavian Journal of Primary Health Care · doi:10.1080/02813430802022196 · Cited by 119
Cullinan, S., O’Mahony, D., O’Sullivan, D., & Byrne, S. (2015) · Age and Ageing · doi:10.1093/ageing/afv166 · Cited by 116
Factors associated with excessive polypharmacy in older people
Walckiers, D., der Heyden, J. V., & Tafforeau, J. (2015) · Archives of Public Health · doi:10.1186/s13690-015-0095-7 · Cited by 113
Anticholinergic burden is associated with recurrent and injurious falls in older individuals
Zia, A., Kamaruzzaman, S. B., Myint, P. K., & Tan, M. P. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.10.009 · Cited by 96
Self-citationVariation Over Time in the Association between Polypharmacy and Mortality in the Older Population
Richardson, K., Ananou, A., Lafortune, L., Brayne, C., & Matthews, F. E. (2011) · Drugs & Aging · doi:10.2165/11592000-000000000-00000 · Cited by 93
Diagnosis and control of polypharmacy in the elderly
de Souza, P. M., dos Santos‐Neto, L. L., Kusano, L. T. E., & Pereira, M. G. (2007) · Revista de Saúde Pública · doi:10.1590/s0034-89102006005000050 · Cited by 89
Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study
Castioni, J., Marques-Vidal, P. M., Abolhassani, N., Vollenweider, P., & Waeber, G. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2793-z · Cited by 89
Is polypharmacy an independent risk factor for adverse outcomes after an emergency department visit?
Salvi, F., Rossi, L., Lattanzio, F., & Cherubini, A. (2016) · Internal and Emergency Medicine · doi:10.1007/s11739-016-1451-5 · Cited by 64
Burt, J., Elmore, N., Campbell, S., Rodgers, S., Avery, A. J., & Payne, R. (2018) · BMC Medicine · doi:10.1186/s12916-018-1078-7 · Cited by 61
Franchi, C., Cartabia, M., RISSO, P., Mari, D., Tettamanti, M., Parabiaghi, A., Pasina, L., Djade, C. D., Fortino, I., Bortolotti, A., et al. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1495-7 · Cited by 57
Risk factors for polypharmacy in older adults in a primary care setting: a cross-sectional study
Ersoy, S., & Engin, V. S. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s176329 · Cited by 48
Characteristics of outpatient prescriptions for frail Taiwanese elders with long‐term care needs
Chan, D., Hao, Y., & Wu, S. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1712 · Cited by 40
A new lexicon for polypharmacy: Implications for research, practice, and education
Gillette, C., Prunty, L., Wolcott, J., & Broedel-Zaugg, K. (2014) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2014.08.010 · Cited by 33
Myint, P. K., & Welch, A. A. (2012) · BMJ · doi:10.1136/bmj.e1214 · Cited by 32
Self-citationGamble, D. T., Clark, A., Luben, R., Wareham, N. J., Khaw, K., & Myint, P. K. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx265 · Cited by 31
Self-citationGeographic region and racial variations in polypharmacy in the United States
Cashion, W. T., Mcclellan, W., Howard, G., Goyal, A., Kleinbaum, D. G., Goodman, M. G., Prince, V., Muntner, P., McClure, L. A., McClellan, A. C., et al. (2015) · Annals of Epidemiology · doi:10.1016/j.annepidem.2015.01.018 · Cited by 30
Narayan, S. W., & Nishtala, P. S. (2015) · Drugs - Real World Outcomes · doi:10.1007/s40801-015-0020-y · Cited by 24
Lee, E. K., & Lee, Y. J. (2013) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-013-9793-9 · Cited by 19
Cited by
Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences
Pazan, F., & Wehling, M. (2021) · European Geriatric Medicine · doi:10.1007/s41999-021-00479-3 · Cited by 542
“While polypharmacy and frailty are highly prevalent in older adults the causal relationship between them is still unclear [11].”
BackgroundResultInfluentialNitric oxide deficiency is a primary driver of hypertension
Bryan, N. S. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115325 · Cited by 77
Sarcopenia and polypharmacy among older adults: A scoping review of the literature
Pana, A., Sourtzi, P., Kalokairinou, A., & Velonaki, V. S. (2022) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2021.104520 · Cited by 57
Prokopidis, K., Giannos, P., Reginster, J. Y., Bruyere, O., Petrovic, M., Cherubini, A., Triantafyllidis, K. K., Kechagias, K. S., Dionyssiotis, Y., Cesari, M., et al. (2023) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13190 · Cited by 51
Metadata
- Authors
- Khezrian, M., McNeil, C. J., Murray, A. D., & Myint, P. K.
- Venue
- Therapeutic Advances in Drug Safety
- Publisher
- SAGE Publications
- Published
- 2020-01
- Volume
- 11
- Pages
- 2042098620933741-2042098620933741
- ISSN
- 2042-0986 (ISSN-L)
- 2042-0994
- OpenAlex
- W3024189091
- Cited by
- 443
- References
- 51
- FWCI
- 23.34
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.